Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer

BACKGROUND: The treatment of metastatic colorectal cancer (mCRC) relies of chemotherapy. The efficacy of the standard FOLFIRI-therapy could be improved by a modification of the regimen by splitting the dose of irinotecan on day 1 and day 3 in the FOLFIRI3 regimen. AIM: To determine safety and effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Devaux, Madeline, Gerard, Laura, Richard, Corentin, Bengrine-Lefevre, Leila, Vincent, Julie, Schmitt, Antonin, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390115/
https://www.ncbi.nlm.nih.gov/pubmed/30815374
http://dx.doi.org/10.5306/wjco.v10.i2.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390115/
https://www.ncbi.nlm.nih.gov/pubmed/30815374
http://dx.doi.org/10.5306/wjco.v10.i2.75

Ejemplares similares